Tinidazole

This classification denotes an antiprotozoal agent with the molecular formula C8H13N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 033KF7V46H, chemically known as 1h-imidazole, 1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro- but generally known as tinidazole, which bears US NIH Compound Identifier 5479. European Medicines Agency schedules Tinidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11074MIG. The term TINIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules tinidazole in its Anatomical Therapeutic Chemical (ATC) Classification. TINIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tinidazole under HS 29332990 and SITC 51573. As of Q4 2014, TINIDAZOLE remains the US FDA Preferred Term for this commodity. Tinidazole bears US NLM identifiers UMLS ID C0040263 and NCI Concept Code C890. SMILES: S(=O)(=O)(CCN1C(NCC1[N](=O)O)C)CC.